Skip to main content

Ensign Peak Advisors, Inc

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1454984 SALT LAKE CITY, UT

Position in SNDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,970,785
-$4,178,250 QoQ
Shares Held
867,831
-12.4% QoQ
Ownership
0.972%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#36
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. SNDX ranks #19 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,970,785 867,831
2026-03-31 $23,149,035 990,969
2025-12-31 $33,585,409 1,598,544
2025-09-30 $12,447,449 809,064
2025-06-30 $6,453,084 689,064
2025-03-31 $8,465,151 689,064
2024-12-31 $3,542,285 267,949
2024-09-30 $6,965,131 361,825
2024-06-30 $10,652,709 518,885
2024-03-31 $12,253,477 514,852
2023-12-31 $11,125,951 514,852
2023-09-30 $7,475,651 514,852
2023-06-30 $8,128,207 388,352
2023-03-31 $4,971,014 235,370
2022-12-31 $5,990,166 235,370
2022-09-30 $5,079,173 211,368
2022-06-30 $2,427,914 126,191
2022-03-31 $1,055,609 60,737
2021-12-31 $1,329,532 60,737
2021-09-30 $3,795,284 198,602
2021-06-30 $963,546 56,118
2021-03-31 $1,254,798 56,118
2020-12-31 $911,328 40,977
2020-09-30 $604,820 40,977
2020-06-30 $266,078 17,954
2020-03-31 $127,350 11,609